Combined Inhibition of SHP2 and Mutated RTKs Prevent Acquired Resistance in Leukemia
November 8, 2023
PRESS RELEASE: On March 31, 2023, a new editorial was published in Oncotarget, entitled, “Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors.” continue reading »